Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Pancreatic Neoplasms HELP
Based on 31,636 articles published since 2008
|||| 49 

These are the 31636 published articles about Pancreatic Neoplasms that originated from Worldwide during 2008-2019.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
126 Editorial Editorial: peptide receptor radionuclide therapy as neoadjuvant therapy for resectable or potentially resectable pancreatic neuroendocrine neoplasms. 2018

Pommier, Rodney F. ·Division of Surgical Oncology, Department of Surgery, Oregon Health & Science University, Portland, OR. Electronic address: pommierr@ohsu.edu. ·Surgery · Pubmed #29422353.

ABSTRACT: -- No abstract --

127 Editorial Concise Commentary: Presurgical Evaluation of IPMNs-Eight Is Enough. 2018

Zyromski, Nicholas J. ·Department of Surgery, Indiana University School of Medicine, Indianapolis, IN, USA. nzyromsk@iupui.edu. ·Dig Dis Sci · Pubmed #29417329.

ABSTRACT: -- No abstract --

128 Editorial Emerging facets in the treatment of patients with hepatopancreaticobiliary malignancies. 2018

McNamara, Mairéad G. ·Department of Medical Oncology, The Christie NHS Foundation Trust, University of Manchester, Withington, Manchester, UK. Electronic address: Mairead.McNamara@christie.nhs.uk. ·Curr Probl Cancer · Pubmed #29397186.

ABSTRACT: -- No abstract --

129 Editorial "International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017": Will this pull us up out of the quagmire of confusing definitions and criteria? 2018

Takaori, Kyoichi. · ·Pancreatology · Pubmed #29389525.

ABSTRACT: -- No abstract --

130 Editorial Intraductal Papillary Mucinous Neoplasm as the Focus for Early Detection of Pancreatic Cancer. 2018

Tanaka, Masao. ·Department of Surgery, Shimonoseki City Hospital, Shimonoseki, Japan. Electronic address: masaotan@med.kyushu-u.ac.jp. ·Gastroenterology · Pubmed #29337154.

ABSTRACT: -- No abstract --

131 Editorial Should Fear of Adverse Events Influence the Decision to Administer Preoperative Therapy to Patients with Pancreatic Cancer? 2018

Katz, Matthew H G. ·Pancreatic Surgical Service, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Mhgkatz@mdanderson.org. ·Ann Surg Oncol · Pubmed #29243201.

ABSTRACT: -- No abstract --

132 Editorial Prediction of pancreatic cancer risk and therapeutic response with next-generation sequencing. 2018

Kyrochristos, Ioannis D / Ziogas, Demosthenes E / Glantzounis, Georgios K / Roukos, Dimitrios H. ·Centre for Biosystems & Genome Network Medicine, Ioannina University, Ioannina, 45110, Greece. · Department of Surgery, Ioannina University Hospital, Ioannina, 45110, Greece. · Department of Surgery, 'G. Hatzikosta' General Hospital, Ioannina, 45001, Greece. · Department of Systems Biology, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, 11527, Greece. ·Biomark Med · Pubmed #29235881.

ABSTRACT: -- No abstract --

133 Editorial The importance of a well-structured pancreatic screening program for familial and hereditary pancreatic cancer. 2018

Vasen, Hans F A. ·Department of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, The Netherlands. hfavasen@stoet.nl. ·Fam Cancer · Pubmed #29204967.

ABSTRACT: -- No abstract --

134 Editorial A Symposium on Pancreatic Cancer: Time for a Paradigm Shift. An Overview and Personal Reflections. 2018

Cooperman, Avram M. ·The Pancreas, Biliary and Advanced Laparoscopy Center of New York, 305 Second Avenue, New York, NY 10003, USA. Electronic address: Avram.cooperman@gmail.com. ·Surg Clin North Am · Pubmed #29191283.

ABSTRACT: -- No abstract --

135 Editorial Challenges Staging Neuroendocrine Tumors of the Pancreas, Jejunum and Ileum, and Appendix. 2018

Nakakura, Eric K. ·Division of General Surgery, Section of Surgical Oncology/Hepatopancreaticobiliary Surgery, Department of Surgery and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. Eric.Nakakura@ucsf.edu. ·Ann Surg Oncol · Pubmed #28779367.

ABSTRACT: -- No abstract --

136 Editorial 8th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary Cancers. 2018

Chun, Yun Shin / Pawlik, Timothy M / Vauthey, Jean-Nicolas. ·Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jvauthey@mdanderson.org. ·Ann Surg Oncol · Pubmed #28752469.

ABSTRACT: -- No abstract --

137 Editorial Prognostic factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): what's better? 2018

Milione, Massimo. ·Department of Pathology and Laboratory Medicine, 1st Division of Pathology, IRCCS Foundation National Cancer Institute, Milan, Italy. Massimo.milione@istitutotumori.mi.it. ·Endocrine · Pubmed #28417314.

ABSTRACT: -- No abstract --

138 Editorial Molecular landscape of pancreatic cancer: challenges and clinical implications. 2017

Kyrochristos, Ioannis D / Ziogas, Demosthenes E / Glantzounis, Georgios K / Roukos, Dimitrios H. ·Centre for Biosystems & Genome Network Medicine, Ioannina University, Ioannina 45110, Greece. · Department of Surgery, Ioannina University Hospital, Ioannina 45500, Greece. · Department of Surgery, 'G Hatzikosta' General Hospital, Ioannina 45001, Greece. · Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens 11527, Greece. ·Future Oncol · Pubmed #29182377.

ABSTRACT: -- No abstract --

139 Editorial [Cystic tumors of the pancreas]. 2017

Hackert, T / Büchler, M W. ·Klinik für Allgemein‑, Viszeral- und Transplantationschirurgie, Universität Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Deutschland. · Klinik für Allgemein‑, Viszeral- und Transplantationschirurgie, Universität Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Deutschland. markus_buechler@med.uni-heidelberg.de. ·Chirurg · Pubmed #29124330.

ABSTRACT: -- No abstract --

140 Editorial Enteric Glia: The Origin of Duodenal Gastrinomas? 2017

Gulbransen, Brian D. ·Neuroscience Program and Department of Physiology, Michigan State University, East Lansing, Michigan. Electronic address: gulbrans@msu.edu. ·Gastroenterology · Pubmed #29100851.

ABSTRACT: -- No abstract --

141 Editorial A plea for more practical and clinically applicable criteria defining type 3c diabetes. 2017

Roeyen, Geert / De Block, Christophe. ·Department of HPB, Endocrine and Transplantation Surgery, Antwerp University Hospital, Belgium. Electronic address: Geert.roeyen@uza.be. · Department of Endocrinology, Diabetology and Metabolic Diseases, Antwerp University Hospital, Belgium. ·Pancreatology · Pubmed #29050930.

ABSTRACT: -- No abstract --

142 Editorial Endoscopic Ultrasound-Guided Pancreatic Cyst Ablation: More Peril Than Promise? 2017

Yachimski, Patrick / Varadarajulu, Shyam. ·Division of Gastroenterology, Hepatology & Nutrition, Vanderbilt University Medical Center, Nashville, Tennessee. · Center for Interventional Endoscopy, Florida Hospital Orlando, Orlando, Florida. ·Gastroenterology · Pubmed #28987419.

ABSTRACT: -- No abstract --

143 Editorial "Revisions of the International Consensus Fukuoka Guidelines for the Management of IPMN of the Pancreas": Progress for twelve years. 2017

Takaori, Kyoichi. ·Department of Surgery, Kyoto University Graduate School of Medicine, 54 Kawara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan. Electronic address: takaori@kuhp.kyoto-u.ac.jp. ·Pancreatology · Pubmed #28864411.

ABSTRACT: -- No abstract --

144 Editorial Pancreatic cyst ablation: why are we not doing more of these procedures? 2017

DeWitt, John M. ·Department of Gastroenterology and Hepatology, Indiana University Health Medical Center, Indianapolis, Indiana, United States. ·Endoscopy · Pubmed #28850976.

ABSTRACT: -- No abstract --

145 Editorial Biomarkers, imaging and multifocality in intraductal papillary mucinous neoplasms: relevant for decision making? 2017

Ansari, Daniel / Aronsson, Linus / Andersson, Roland. ·Department of Surgery, Clinical Sciences Lund, Lund University, Skåne University Hospital, Lund, Sweden. ·Future Oncol · Pubmed #28831817.

ABSTRACT: -- No abstract --

146 Editorial Peritoneal Metastases from Gastroenteropancreatic Neuroendocrine Tumors. 2017

Frilling, Andrea / Clift, Ashley K. ·Department of Surgery and Cancer, Imperial College London, London, UK. a.frilling@imperial.ac.uk. · Department of Surgery and Cancer, Imperial College London, London, UK. ·Ann Surg Oncol · Pubmed #28815440.

ABSTRACT: -- No abstract --

147 Editorial Editorial: Stopping Pancreatic Cyst Surveillance? 2017

Farrell, James J. ·Yale Pancreatic Disease Program, Interventional Endoscopy, Yale School of Medicine, New Haven, CT, USA. ·Am J Gastroenterol · Pubmed #28725064.

ABSTRACT: The management of patients with pancreatic cysts, especially presumed branch duct intraductal papillary mucinous neoplasms (BD-IPMNs), remains a challenge. BD-IPMNs carry a very low risk of malignancy and occur in predominantly older individuals who often die from causes not related to their pancreatic disease. The specific decision to stop surveillance of presumed low risk BD-IPMNs (those without either worrisome features (WF) or high risk stigmata (HRS)) is controversial, and needs to balance the real risk of malignancy or developing malignancy and IPMN-related mortality, with the patient's life expectancy, quality of life expectations, and mortality from non-pancreatic-related causes. With improved life expectancy, improved survival from non-pancreatic malignancies, rising health costs, and growing detection of ever smaller presumed BD-IPMNs, this issue is becoming ever more critical.

148 Editorial Pancreatic cancer screening. 2017

Soldan, Mônica. ·- Federal University of Rio de Janeiro, Clementino Fraga Filho University Hospital, Gastroenterology Service, Rio de Janeiro, RJ, Brazil. · - São Vicente de Paulo Hospital, Endoscopy Service, Rio de Janeiro, RJ, Brazil. ·Rev Col Bras Cir · Pubmed #28658327.

ABSTRACT: -- No abstract --

149 Editorial Which Is Crucial, Strengthen the Foundation or Building the Dream House? 2017

Isayama, Hiroyuki / Nakai, Yousuke / Fujisawa, Toshio. ·Department of Gastroenterology, Graduate School of Medicine, Juntendo University, Tokyo, Japan. · Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. ·Gut Liver · Pubmed #28647955.

ABSTRACT: -- No abstract --

150 Editorial Role of surgery in pancreatic cancer. 2017

Buanes, Trond A. ·Trond A Buanes, Department of Hepato-Pancreatico-Biliary Surgery, Oslo University Hospital, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Pb 4956 N-0424 Oslo, Norway. ·World J Gastroenterol · Pubmed #28638216.

ABSTRACT: Treatment of pancreatic cancer is multimodal and surgery is an essential part, mandatory for curative potential. Also chemotherapy is essential, and serious postoperative complications or rapid disease progression may preclude completion of multimodal treatment. The sequence of treatment interventions has therefore become an important concern, and numerous ongoing randomized controlled trials compare clinical outcome after upfront surgery and neoadjuvant treatment with subsequent resection. In previous years, borderline resectable and locally advanced pancreatic cancer was most often considered unresectable. More effective chemotherapy together with the latest improvements in surgical expertise has resulted in extended operations, pushing the borders of resectability. Multivisceral resections with or without resection of major mesenteric vessels are now performed in numerous patients, resulting in better outcome, recorded as overall survival and/or patient reported outcome. But postoperative morbidity increases concurrently, and clinical benefit must be carefully evaluated against risk of potential harm, associated with new comprehensive multimodal treatment sequences. Even though cost/utility analyses are deficient, extended surgery has resulted in significantly longer and better life for many patients with no other treatment alternative. Improved selection of patients to surgery and/or chemotherapy will in the near future be possible, based on better tumor biology insight. Clinically available biomarkers enabling personalized treatment are forthcoming, but these options are still limited. The importance of surgical resection for each patient's prognosis is presently increasing, justifying sustained expansion of the surgical treatment modality.

Back · Next